The WTO finds fault with both sides in a long-running row over an EU ban on US beef treated with hormones.

The Argentine government is set to announce a series of steps try to end a farmers strike, local media report.

The US Treasury is set to reveal its blueprint for overhauling the regulation of the financial sector.

Improve your intellect with tours that focus on literature, art and history.

Richard Helm, manager of the Cohen & Steers Dividend Value Fund, looks for dividend darlings in the rough.

Forget the bum economy. Across the globe, a new generation of sports stadiums are rising.

In these ten spots, fleeing lenders, rampant foreclosures, stalled sales and few new jobs hamper growth.

Amid the credit crunch, 14 bond issuers managed to get back to investment grade in the first quarter.

Swiss press says the bank may be preparing for a $16.1 billion capital injection.


Competitor Vertex is set to announce positive data for a hepatitis C treatment.

Wall Street looks to start the healing Tuesday after a shabby first three months of 2008.

Lead investigator of ENHANCE trial threatened to quit, according to incendiary messages released by senator.

Unlike comeback kids Apple and H-P, desktop PC giant will have to up spending on new products, even as it scales back costs.

Drugmakers dive as study suggests limited use for cholesterol treatment.

Food shares fall after a USDA report says farmers will plant less of the crop in 2008.

Hawaii’s second-largest airline brings over 60 years of its business to a close.

The European Central Bank may not cut interest rates at all for the rest of 2008.

Good news for AstraZeneca’s cholesterol pill Crestor is bad news for the makers of Zetia and Vytorin.

Swiss press says the bank may be preparing for a $16.1 billion capital injection.

U.S. brokerage claims employees of the Japanese trading house bilked it out of $350 million.

The “open skies” deal between the US and Europe comes into effec, aiming to open up air travel.

Anxiety is deepening among researchers about the cholesterol drugs Zetia and Vytorin. Bad news for Merck and Schering-Plough.

Anxiety deepens about Merck and Schering-Plough’s $5.2 billion cholesterol franchise.

Treasury Secretary Henry Paulson’s proposed U.S. financial regulation overhaul aims to bring an outdated system in line with modern markets.

keep looking »